Who we are
At Edel Ventures, science and commercial acumen sit at the same table. Our core team is built around board‑certified medical doctors educated in the United States and Europe working shoulder‑to‑shoulder with seasoned pharmaceutical executives who have shepherded breakthrough molecules, medical devices and nutraceuticals through APAC’s regulatory and retail gauntlets for more than two decades.
That blend of clinical rigour and market know‑how means we do not gamble on catalogue volume—we pursue undisputed category leadership. Before we champion a brand, we dissect its clinical dossier, audit the supply chain, size the Thai addressable market and map every competitive moat. Second best is not adequate for us, nor for the physicians, athletes and consumers we serve.
Because we commit significant capital—cold‑chain infrastructure, multilingual KOL education programs and seven‑figure launch budgets—we insist on exclusive distribution rights. Exclusivity protects our shared upside, lets us uphold premium pricing, and guarantees that your brand receives the strategic focus that turns evidence‑based innovation into a household name.
Why Thailand?
US $4.1 b supplement & functional‑beverage market in 2024, forecast 5 % CAGR to 2030.
14 % of the population is 65+ and seeking healthy‑ageing solutions.
18 m active social‑media fitness enthusiasts driving demand for clean energy, recovery and nootropics.
E‑commerce penetration >60 % in Bangkok & tier‑one cities.
Opportunity for global innovators: Rapid brand adoption when products combine science, certification and story.
Why Edel Ventures?
Regulatory Mastery
We navigate Thai FDA, Novel‑Food and excise requirements end‑to‑end—average dossier approval in 8 weeks.
Omnichannel Distribution
Nation‑wide fulfilment through Boots, Watsons, Tops Market, leading fitness chains and Thailand’s top three e‑commerce platforms.
Brand Protection & Marketing
In‑house creative + KOL network (2 m combined followers) deliver premium storytelling while enforcing MAP pricing to deter grey imports.
Data‑Driven Launch
We run micro‑market tests, track sell‑through with real‑time POS dashboards and iterate campaigns weekly.
Performance‑Based Exclusivity
We co‑invest in inventory and marketing, commit to volume milestones, and never dilute focus with competing SKUs.
Value Snapshot (3 quick stats)
500+ retail points of sale across Thailand’s pharmacy, fitness and lifestyle channels
8‑week average Thai FDA approval timeline achieved per SKU
10× average first‑year revenue uplift for partner brands